Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110719 · ClinicalTrials.gov registry record · Phase 4
Decreasing Narcotics in Advanced Pelvic Surgery
A Phase 4 study, sponsored by Hartford Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 138
- Enrollment target
NCT02110719 is a Phase 4 study that has completed, run by Hartford Hospital. The registered enrollment target is 138 participants.
The verdict
NCT02110719, a Phase 4 study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 138 participants
- Enrollment target
Study Summary
In recent years, there has been an emphasis on the creation of "enhanced-recovery", "fast-track" or "multi-modal" pathways to improve perioperative care (1-4). The goal of these programs is to reduce the length of hospital stay, decrease narcotic usage while improving pain control, accelerate post-operative recovery, and expedite return to baseline functional status. Pathways often are developed by a team of surgeons, nurses, pain specialists, anesthesiologists and other support staff. Postoperative components often involve multi-modal analgesia, early return to activity and early return to a regular diet. The goal of this study is to evaluate the efficacy of a multi-modal pain regimen in advanced pelvic surgery with a primary goal of decreasing narcotic usage.
Interventions
- DRUG Gabapentin
- DRUG IV acetaminophen
- DRUG Celebrex
- DRUG oral ibuprofen
- DRUG oral acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02110719
The ClinicalTrials.gov registry entry for NCT02110719 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Gabapentin is the first listed.
NCT02110719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02110719 about?
NCT02110719 is a clinical study titled "Decreasing Narcotics in Advanced Pelvic Surgery". In recent years, there has been an emphasis on the creation of "enhanced-recovery", "fast-track" or "multi-modal" pathways to improve perioperative care (1-4). The goal of these programs is to reduce the length of hospital stay, decrease narcotic usage while improving pain control, accelerate post-o...
What is the current status of trial NCT02110719?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 138 participants. The study started on 2014-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02110719?
The interventions under investigation include: Gabapentin (DRUG), IV acetaminophen (DRUG), Celebrex (DRUG), oral ibuprofen (DRUG), oral acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02110719?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.